BRPI0519991A2 - derivados de imidazo-benzodiazepina - Google Patents

derivados de imidazo-benzodiazepina

Info

Publication number
BRPI0519991A2
BRPI0519991A2 BRPI0519991-3A BRPI0519991A BRPI0519991A2 BR PI0519991 A2 BRPI0519991 A2 BR PI0519991A2 BR PI0519991 A BRPI0519991 A BR PI0519991A BR PI0519991 A2 BRPI0519991 A2 BR PI0519991A2
Authority
BR
Brazil
Prior art keywords
lower alkyl
benzodiazepine derivatives
imidazo
cycloalkyl
aryl
Prior art date
Application number
BRPI0519991-3A
Other languages
English (en)
Inventor
Andreew William Thomas
Henner Knust
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0519991A2 publication Critical patent/BRPI0519991A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DE IMIDAZO-BENZODIAZEPINA. A presente invenção refere-se a derivados de imidazoil ,5-a][1 ,2, 4jltriazolo[1 ,5-d][1 ,4]benzodiazepina substituida da seguinte fórmula (l) onde R¹2 é hidrogênio, halogênio, alquila inferior, alquinila inferior, ciclo- alquila, heterocicloalquila, benzila, ciano, alcóxi inferior, OCF~ 3~, -NHR, -NHC (O)R ou -NHSO~ 2~R; R² é alquila inferior substituida com halogênio; R³ é hidrogênio, metila ou arila; R é alquila inferior, cicloalquila ou arila; e a seus sais de adição de ácido farmaceuticamente aceitáveis. Foi descoberto que esta classe de compostos apresenta alta afinidade e seletividade para sítios de ligação do receptor de GABA A <244>5 e podem ser úteis como aumentador cognitivo ou para o tratamento de distúr- bios cognitivos, ansiedade, esquizofrenia ou mal de Alzheimer.
BRPI0519991-3A 2004-10-20 2005-10-11 derivados de imidazo-benzodiazepina BRPI0519991A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105169 2004-10-20
PCT/EP2005/010908 WO2006045430A1 (en) 2004-10-20 2005-10-11 Imidazo-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
BRPI0519991A2 true BRPI0519991A2 (pt) 2009-04-07

Family

ID=36035782

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519991-3A BRPI0519991A2 (pt) 2004-10-20 2005-10-11 derivados de imidazo-benzodiazepina

Country Status (18)

Country Link
US (1) US7514426B2 (pt)
EP (1) EP1805184B1 (pt)
JP (1) JP4783375B2 (pt)
KR (1) KR100923399B1 (pt)
CN (1) CN101044145B (pt)
AR (1) AR051395A1 (pt)
AU (1) AU2005299032B2 (pt)
BR (1) BRPI0519991A2 (pt)
CA (1) CA2584259C (pt)
ES (1) ES2399439T3 (pt)
IL (1) IL182585A0 (pt)
MX (1) MX2007004639A (pt)
NO (1) NO20071967L (pt)
NZ (1) NZ554439A (pt)
RU (1) RU2007112940A (pt)
TW (1) TWI303247B (pt)
WO (1) WO2006045430A1 (pt)
ZA (1) ZA200703172B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1828194B1 (en) * 2004-12-14 2008-05-28 F. Hoffmann-Roche AG Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
BRPI0617204A2 (pt) * 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
FR2913886B1 (fr) 2007-03-22 2012-03-02 Guerbet Sa Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer
EP2298296A1 (en) 2009-08-25 2011-03-23 CNRS Centre National De La Recherche Scientifique Composition and method for treating cognitive impairments in down syndrome subjects
WO2011153377A2 (en) * 2010-06-03 2011-12-08 The Regents Of The University Of California Methods and compositions for treating a subject for central nervous system (cns) injury
MX341471B (es) * 2010-11-05 2016-08-22 Hoffmann La Roche Uso de compuestos farmaceuticos activos para el tratamiento de estados patologicos del sistema nervioso central.
EP2457569A1 (en) 2010-11-05 2012-05-30 F. Hoffmann-La Roche AG Use of active pharmaceutical compounds for the treatment of central nervous system conditions
EP3034079B1 (en) 2010-11-15 2018-01-10 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
NZ760341A (en) * 2013-12-20 2021-12-24 Agenebio Inc Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX392119B (es) 2015-06-19 2025-03-11 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112020004116A2 (pt) * 2017-08-28 2020-09-01 University Of Maryland, Baltimore novos moduladores do receptor de ácido gama aminobutírico tipo a para distúrbios de humor
CN112601749B (zh) 2018-06-19 2024-03-26 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物，组合物和方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
IL74070A (en) 1984-01-19 1988-12-30 Hoffmann La Roche Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
ZA881538B (en) * 1987-03-10 1988-09-12 F. Hoffmann-La Roche & Co. Aktiengesellschaft Imidazodiazepine derivatives
US4897392A (en) 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
TW201311B (pt) * 1991-06-17 1993-03-01 Hoffmann La Roche
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives

Also Published As

Publication number Publication date
WO2006045430A1 (en) 2006-05-04
CN101044145A (zh) 2007-09-26
CA2584259C (en) 2013-04-02
EP1805184B1 (en) 2013-01-09
NZ554439A (en) 2009-09-25
CN101044145B (zh) 2010-06-16
TW200630372A (en) 2006-09-01
US7514426B2 (en) 2009-04-07
US20060084642A1 (en) 2006-04-20
ZA200703172B (en) 2008-08-27
KR100923399B1 (ko) 2009-10-23
NO20071967L (no) 2007-05-14
AU2005299032B2 (en) 2011-11-17
AU2005299032A1 (en) 2006-05-04
TWI303247B (en) 2008-11-21
IL182585A0 (en) 2007-07-24
JP4783375B2 (ja) 2011-09-28
RU2007112940A (ru) 2008-11-27
JP2008517011A (ja) 2008-05-22
ES2399439T3 (es) 2013-04-01
EP1805184A1 (en) 2007-07-11
AR051395A1 (es) 2007-01-10
CA2584259A1 (en) 2006-05-04
KR20070054731A (ko) 2007-05-29
MX2007004639A (es) 2007-06-08

Similar Documents

Publication Publication Date Title
BRPI0519991A2 (pt) derivados de imidazo-benzodiazepina
KR102256013B1 (ko) 척수성 근위축증을 치료하기 위한 화합물
CN107635999B (zh) 用于治疗脊髓性肌萎缩的化合物
NO20072046L (no) Halogensubstituerte benzodiazepinderivater
NZ590777A (en) PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE FOR INHIBITING mTOR
PE20030129A1 (es) Imidazotriazinas
MX2007006896A (es) Fenil-metanonas bi- y triciclicas sustituidas como inhibidores del transportador 1 de glicina (glyt-1) para el tratamiento de la enfermedad de alzheimer.
MA29437B1 (fr) Compose d&#39;imidazopyridazine
CO4650043A1 (es) PIRIMIDO (5,4-d)PIRIMIDINAS, MEDICAMENTOS QUE CONTIENEN ESTOS COMPUESTOS Y PROCEDIMIENTO PARA SU PREPARACION .
TW200736257A (en) Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives
IL190398A0 (en) Imidazo benzodiazepine derivatives
MXPA03010529A (es) Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a.
MX2007004250A (es) Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos.
TW200734328A (en) Aryl-isoxazolo-4-yl-imidazo [1,5-a] pyridine derivatives
BRPI0515800A (pt) imidazo-benzodiazepinas tetracìclicas como moduladores de receptores de gaba
WO2007054444A3 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
ES2238260T3 (es) Derivados cianoindol como inhibidores de recaptura de la serotonina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
TH79587A (th) อนุพันธ์ของอิมิดาโซ-เบนโซไดอะซีพีน
EP1718299A1 (en) Heterocyclic gaba-a subtype selective receptor modulators
JP2007517794A (ja) ピロロピリミジン及びピロロトリアジン誘導体
BRPI0606730A2 (pt) derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos
TH82743B (th) อนุพันธ์เบนโซไดอะซีพีนซึ่งถูกแทนที่ด้วยฮาโลเจน
HK1246784B (zh) 用於治疗脊髓性肌萎缩的化合物
UY27294A1 (es) Derivados de imidazo (1, 5-a) pirimido (5, 4-d) benzazepina
TH80293A (th) เตตระไซคลิก อิมมิดาโซ-เบนโซไดอะซีพิน

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]